Regenera Activa: One Session, and What It Can and Cannot Do

Reviewed by Dr Cindy Yang | Founder and Medical Director, Dr Cindy’s Medical Aesthetics, Singapore. Practising aesthetic medicine since 2006.

Regenera Activa is a single-session treatment for pattern hair loss that uses tissue taken from your own scalp. A small sample is harvested from an area that is relatively resistant to thinning, mechanically processed into an autologous suspension containing cells and signalling components derived from scalp tissue, and administered into the areas that are thinning. The whole procedure takes up to 45 minutes, and repeat treatment may be considered depending on what the follow-up evaluation shows.

That is the summary. It is unusual among hair loss treatments in two respects, and both are worth understanding before you decide whether it is for you.

The first is that it can be performed as a single session rather than necessarily requiring a course of closely spaced appointments, which changes how you should think about the cost and the commitment. The second is that the material administered comes from your own scalp, rather than from donor tissue or an externally prepared biological product.

This article is about candidacy. Not whether the treatment works in general, but whether it is the right treatment for the hair loss you actually have, and what it will and will not do. Those are different questions, and the second one is where much of the disappointment with hair-loss treatment originates.

What it actually is

The clinical name is autologous skin micrografting. Autologous means the tissue comes from the patient rather than a donor. Micrografting describes the processing: small samples of scalp tissue are mechanically processed into a suspension containing cells and signalling components derived from that tissue.

The clinic’s indication is androgenetic alopecia, which is pattern hair loss and the most common cause of progressive hair loss in both men and women. The treatment is intended to support the activity of follicles that are still present by using material derived from the patient’s own scalp.

That last point has a practical consequence. Because the material comes from your own tissue, immunological rejection of donor tissue is not expected and there is no donor material to trigger a donor-specific allergic response.

What is not absent is the ordinary risk profile of a minor procedure. You are having small tissue samples taken under local anaesthesia and receiving multiple injections into the scalp. That carries considerations including discomfort, bruising, tenderness, bleeding, swelling and healing at the donor site, as well as other procedure-specific risks that should be discussed beforehand.

Autologous removes the donor-tissue question. It does not make the procedure risk-free.

The three phases, and what the appointment involves

The procedure has three parts and takes up to 45 minutes in total. It is performed by doctors registered with the Singapore Medical Council.

Harvest. The doctor examines your scalp to identify suitable donor sites, typically at the back of the scalp because this area is relatively resistant to androgenetic hair loss. A small area is shaved, local anaesthesia is administered, and tissue samples are taken with a punch biopsy tool. The donor sites are then cared for while they heal.

The shaving is worth flagging because it matters practically. It is a small area at the back of the scalp and surrounding hair can usually help conceal it, but it is a real consideration if you have an event shortly afterwards or wear your hair very short.

Processing. A specialised device mechanically processes the tissue samples into an autologous suspension containing cellular and signalling components from the scalp tissue. This happens during the same appointment, so the prepared material can be used immediately.

Administration. The prepared suspension is administered through multiple small injections into selected areas of thinning.

Local anaesthesia is used for the harvest, which distinguishes this from treatments where topical anaesthetic alone may be sufficient. Go in understanding that this is a small procedure, with everything that implies.

Downtime and what follows

Downtime is generally limited. Regenera Activa is minimally invasive, and most patients can return to ordinary activities relatively quickly after the procedure, although the donor sites and treated scalp may be temporarily tender, red or swollen.

You will be given instructions on caring for the scalp afterwards, including when you can wash your hair and whether particular products or activities should be avoided temporarily. Follow-up is used to assess healing and, over the following months, the response to treatment.

Repeat treatment may be considered following reassessment. If the clinic recommends repeating the procedure at around a year in an appropriate patient, that is a treatment strategy based on follow-up rather than a rule that every patient must repeat it on a fixed annual schedule.

Other hair-loss treatments may also be recommended depending on the diagnosis. That can include appropriate topical treatment, medical treatment or nutritional support where there is an indication for it. Which hair growth supplements and topical products have evidence behind them covers that part separately.

What results look like, and on what timeline

Clinical studies of autologous scalp micrografting in androgenetic alopecia have reported improvements in measures such as hair count and density following treatment. The clinic’s in-depth review of Regenera Activa for hair restoration covers the efficacy question specifically.

The evidence is encouraging, but expectations still need to be realistic. Studies vary in their design, treatment protocols and methods of measuring improvement, and the evidence base is smaller than that for established medical treatments for androgenetic alopecia.

Hair grows in cycles measured in months. Even where a follicle responds to treatment, it still has to produce a hair long enough and thick enough to contribute visibly to coverage. That means changes should be assessed over months rather than days or weeks.

Some patients may notice changes in shedding or hair quality before they see an obvious difference in density. Visible improvement, where it occurs, is gradual, and individual response varies.

Candidacy matters because these treatments depend on follicles that retain the capacity to produce hair. The degree and duration of miniaturisation, pattern and severity of hair loss, age, underlying diagnosis and other treatments being used can all influence what is realistically achievable.

Photographs of the same areas in consistent lighting, taken at baseline and during follow-up, are far more reliable than your impression in the mirror, which adapts to gradual change without registering it.

What it cannot do

This is the section that determines whether you will be satisfied, and it comes down to one biological constraint.

It works with follicles that are still capable of responding. In androgenetic alopecia, follicles progressively miniaturise and produce shorter, finer hairs. Autologous micrografting is intended to support the activity of follicles that remain present rather than create entirely new follicles.

Where an area has been completely bald for years, the likelihood of meaningful regrowth with a non-surgical treatment is much lower.

The practical implication is useful: earlier pattern hair loss, where miniaturising follicles are still producing hair, generally gives a non-surgical treatment more to work with than longstanding complete baldness.

A patient with diffuse thinning and variation in hair calibre may still have substantial follicular activity across the affected area. A longstanding bald area is a different proposition. This is why a doctor assesses suitability before proceeding rather than afterwards, and why an honest assessment may conclude that some areas are more realistic treatment targets than others.

It does not remove the underlying tendency to pattern hair loss. Androgenetic alopecia is a progressive condition involving genetically susceptible follicles and androgen signalling. A regenerative procedure does not remove that susceptibility.

That means follow-up and longer-term management matter. Further treatment may be considered according to the response and subsequent progression, rather than assuming that one session permanently removes the underlying condition.

It is not a hair transplant, and it does not replace one. They are different procedures with different purposes. Micrografting processes a small sample of scalp tissue and administers the resulting preparation with the aim of supporting existing follicles. It does not relocate follicles.

Hair transplantation moves actual follicular units from a donor area to a recipient area and can therefore create coverage in areas where non-surgical treatment is unlikely to produce enough regrowth. Micrografting works with follicles already in the treatment area; transplantation physically moves follicles into it. The clinic does not perform hair transplantation, so where transplantation is the more appropriate option, that should be part of an honest discussion.

It is not the same as PRP, and the difference begins with what is harvested. Platelet-rich plasma is prepared from the patient’s blood and concentrates platelets in a plasma preparation. Autologous scalp micrografting instead begins with small samples of scalp tissue that are mechanically processed into a suspension.

Both are autologous, but they are different preparations with different source tissues, processing methods and treatment protocols. One should not be treated simply as a stronger version of the other.

It does not substitute for a diagnosis. If your hair loss is primarily a shedding episode after an illness, iron deficiency, thyroid dysfunction or another medical problem, micrografting does not correct that underlying cause. Working out which type you have comes first.

Where a systemic or scalp condition is contributing to the hair loss, it may need to be addressed before or alongside any procedure. The assessment establishes that before treatment is considered.

Who it suits

Drawing the above together, the stronger candidates share a profile.

Pattern hair loss rather than an unexplained shedding episode or untreated medical cause, confirmed on assessment. Thinning areas where follicles are still producing hair, often with variation in hair calibre consistent with miniaturisation. And a suitable donor area from which the small tissue samples can be taken.

There should also be no untreated systemic driver or active scalp infection or significant inflammatory scalp condition that needs to be addressed first.

A preference for a treatment that can be performed as a single procedure rather than a closely spaced course of appointments may also make micrografting attractive to some patients.

Less suitable are longstanding areas of complete baldness where the likelihood of meaningful non-surgical regrowth is low, hair loss that has not yet been diagnosed, or an untreated deficiency, thyroid disorder or scalp condition that should be addressed first.

It is also not the right treatment for someone expecting a definitive one-off cure for pattern hair loss. The underlying tendency to miniaturisation remains, and longer-term management should be discussed according to the diagnosis and response.

How it sits alongside everything else

Regenera Activa is one of three in-clinic procedures the clinic uses for hair loss, but the choice between them should follow the diagnosis rather than be treated as a menu of interchangeable upgrades.

The other two, fractional laser therapy with exosome and microneedling with radiofrequency, treat the scalp in a different way. Microneedling creates microscopic channels mechanically, while fractional laser delivers energy into microscopic treatment zones and can temporarily alter the skin barrier. Both can also be paired with a topical preparation applied afterwards.

Autologous micrografting differs because the treatment material comes from the patient’s own scalp tissue and is administered directly into selected areas by injection.

Neither approach is automatically superior. The relevant questions are what type of hair loss you have, where the thinning is occurring, how much viable follicular activity remains, what each treatment is intended to accomplish and what evidence supports it.

More than one treatment may sometimes form part of a longer-term plan, but combination treatment should have a reason. A longer list of treatments is not automatically a better plan.

The same applies to daily treatment. Someone with a documented nutritional deficiency may need that corrected. Someone with an inflammatory scalp condition needs that condition treated. Someone with androgenetic alopecia may need to discuss established medical treatments as well as procedural options. Supplements and topical scalp products can have a role where there is a reason to use them, but they are not automatically required simply because micrografting has been performed.

Pricing sits in two places rather than here. The clinic’s own hair loss treatment cost guide covers the range, and its Regenera Activa treatment cost guide covers this procedure specifically. Both carry current figures, which an article cannot.

What a consultation establishes

Before treatment the doctors assess whether your hair loss is suitable for autologous skin micrografting. That assessment is the whole point of the appointment.

It begins with a detailed history: onset, duration and pattern of the loss, family history, recent illnesses, medications, diet and relevant lifestyle factors. That is followed by a physical examination of the scalp and hair, assessing distribution, pattern and extent and looking for inflammation, infection or other dermatological conditions.

Where the history and examination suggest a systemic cause, further investigations may follow. The scalp is also examined specifically for suitable donor sites and for signs that the follicles in the areas of concern are still viable treatment targets.

You should leave knowing whether your hair loss is pattern hair loss and whether there is enough follicular activity in the areas that concern you for this treatment to be worthwhile. You should also know whether anything needs correcting first, whether the areas most likely to respond are the ones you came in concerned about, and what a realistic timeline looks like.

A recommendation to treat a different area than expected, to use another treatment instead, or to correct something else first is not a failed consultation. It is a sign that candidacy was actually assessed.

Where to be seen, and who sees you

Dr Cindy’s Medical Aesthetics performs this treatment at both clinics as part of its hair loss and thinning treatment range, alongside the wider options in the guide to hair loss treatment in Singapore.

Orchard. 360 Orchard Road, #05-06 International Building, Singapore 238869. Monday and Thursday 11.30am to 7pm, Tuesday, Wednesday and Friday 10am to 8pm, Saturday 10am to 3pm. Closed Sunday and public holidays.

Tampines. 1 Tampines Central 5, #07-01 CPF Tampines Building, Singapore 529508. Monday to Friday 11.30am to 9pm, Saturday 10am to 7pm. Closed Sunday and public holidays.

The procedure is performed by doctors registered with the Singapore Medical Council: Dr Cindy Yang, founder and medical director, Dr Eugene Lim, and Dr Grace Su, a general practitioner working in aesthetic and lifestyle medicine.

Where it is not us: if what you need is restoration of an area where hair has been absent for years, transplantation rather than micrografting is the appropriate procedure and this clinic does not perform it. If the scalp is painful, scaling, blistering or scarred, or the loss is patchy with well-defined circular borders, that warrants dermatological assessment before any procedure.

The question worth asking about this treatment is whether you still have enough viable follicular tissue in the areas that concern you for it to work on. That is what the assessment is for, and it is worth having before you commit to anything.

Frequently asked questions

What is Regenera Activa?

A single-session treatment for pattern hair loss, clinically named autologous skin micrografting. A small tissue sample is taken from a healthy area of your own scalp under local anaesthesia, processed with a specialised device into an injectable suspension of regenerative cells, and injected into thinning areas through multiple small injections. The whole procedure takes up to 45 minutes.

Does Regenera Activa work for hair loss?

It is indicated for androgenetic alopecia, and the clinic’s stated results are reduced hair loss with improvements in hair density, hair quality and scalp coverage. Gradual improvement can be observed as early as one month, with continued benefit reported up to a year and beyond. Results vary between individuals, and the variable that matters most is how much viable follicular tissue remains in the area being treated.

What is autologous skin micrografting?

The clinical name for the procedure. Autologous means the tissue comes from you rather than a donor. Micrografting describes processing scalp tissue into very small fragments to release the regenerative cells and signalling molecules within it, which are then injected. Because the material comes from your own scalp rather than from donor tissue or an externally prepared biological product, the considerations that apply to donor material do not arise.

How long do Regenera Activa results last?

Evaluation studies show continued hair growth benefit up to a year and beyond, and the clinic’s guidance is that the treatment can be repeated annually depending on what the follow-up evaluation shows. It is sustained by repeating rather than being a one-off, because the underlying androgen sensitivity that drives pattern hair loss is not removed by treating it.

Is Regenera Activa a single-session treatment?

Yes, and that is one of its distinguishing features. Harvest, extraction and injection all happen in one appointment of up to 45 minutes, rather than across a course. A repeat is considered annually based on the follow-up evaluation rather than scheduled in advance.

Who is suitable for Regenera Activa?

Patients with confirmed pattern hair loss, thinning that still shows mixed hair calibre indicating miniaturising follicles are present, a healthy donor area at the back of the scalp, and no untreated systemic driver or active scalp condition. Less suitable are long-established complete baldness in the target area, undiagnosed hair loss, and untreated deficiency or thyroid problems. Suitability is assessed before treatment rather than assumed.

What is the difference between Regenera Activa and a hair transplant?

They do different jobs. Micrografting takes a small sample, processes it into a cell suspension, and injects it to stimulate follicles that are already present but underperforming. It does not move follicles. Transplantation relocates actual follicular units from a donor area into a recipient area, which is what can restore coverage where follicles are genuinely gone. Micrografting improves what you have; transplantation moves what you have. This clinic performs the former, not the latter.

Is Regenera Activa different from PRP for hair?

Yes, in what is harvested and what is injected. Platelet-rich plasma is prepared from blood, concentrating platelets and the growth factors they release. Micrografting is prepared from scalp tissue and yields a suspension containing regenerative cells and progenitor cells as well as growth factors. Both are autologous, so neither carries a rejection risk, and they differ in source tissue, preparation and typical treatment schedule.

What happens during a Regenera Activa session?

Three phases in one appointment. The doctor identifies healthy donor sites, usually at the back of the scalp; the area is shaved and local anaesthesia given before samples are taken. A specialised device processes those samples into an injectable suspension. The suspension is then injected into the thinning areas through multiple small injections. Up to 45 minutes in total, with no significant downtime, and you can typically resume normal activities immediately.

When do you see results after Regenera Activa?

Gradual improvements in hair quality, density and coverage can be observed as early as one month, with continued benefit reported up to a year and more. What appears at one month is early change in hair quality rather than restored coverage, because the growth cycle sets the pace and a stimulated follicle still has to grow a visible hair. Monthly photographs in consistent lighting are the reliable way to judge it.

References

1. Orentreich N. Autografts in alopecias and other selected dermatological conditions. Ann N Y Acad Sci. 1959;83:463-479.